TELO Telomir Pharmaceuticals, Inc. - Common Stock
$1,23
Fiyat · May 20, 2026
Temel veriler itibarıyla May 14, 2026
52 Haftlık Aralık
$1–$3
8% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
-4.0
ROE
-325.7%
Net Kâr Marjı
—
TELO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.23
Piyasa Değeri
$46M
P/E (TTM)
-4.0
EPS (TTM)
$-0.33
Gelir (TTM)
—
Temettü Verimi
—
ROE
-325.7%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $3
TELO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-0.33
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
TELO
Akran Ortalaması
P/E (TTM)
-4.0
22.6
P/B (F/D)
7.7
3.5
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
TELO
Akran Ortalaması
ROA
-240.3%
-62.6%
ROE
-325.7%
-59.0%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
TELO
Akran Ortalaması
Current Ratio (Cari Oran)
5.1
2.7
Quick Ratio (Cari Oran)
5.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
TELO
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
TELO
Akran Ortalaması
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.05%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Aralık 2025 | $-0.28 | $-0.07 | -0.21% |
| 30 Eylül 2025 | $-0.03 | $-0.07 | 0.04% |
| 30 Haziran 2025 | $-0.17 | $-0.08 | -0.09% |
| 31 Mart 2025 | $-0.07 | $-0.10 | 0.03% |
| 31 Aralık 2024 | $-0.10 | $-0.05 | -0.05% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TELO | $46M | -4.0 | — | — | -325.7% | — |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | — |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| LONA | $71M | -0.3 | — | — | -353.4% | — |
| CPIX | $60M | -20.9 | 17.6% | -6.4% | -11.9% | — |
| BTMD | — | 3.5 | -2.5% | 14.1% | -32.9% | — |
| PLRX | $75M | -0.5 | -83.7% | — | -74.4% | — |
| RFL | — | -1.6 | 44.0% | -3328.2% | -34.6% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $2M | $833.2K | |
| SG&A Expense | $8M | $10M | $600.2K | $20.9K | |
| Operating Expenses | $11M | $12M | $4M | $854.1K | |
| Interest Expense | · | · | $2M | · | |
| Interest Income | $125.6K | $48.0K | · | · | |
| Net Income | $-10M | $-17M | $-13M | $-854.1K | |
| EPS (Basic) | $-0.33 | $-0.56 | $0.48 | $-0.03 | |
| EPS (Diluted) | $-0.33 | $-0.56 | $0.48 | $-0.03 | |
| Shares (Basic) | 31,653,094 | 29,539,219 | 27,304,724 | 26,829,284 | |
| Shares (Diluted) | 31,653,094 | 29,539,219 | 27,304,724 | 26,829,284 |
Bilanço 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $1M | $1.2K | $1.4K | |
| Prepaid Expense | $54.7K | $57.9K | $713 | · | |
| Current Assets | $7M | $1M | $435.2K | $48.7K | |
| Total Assets | $7M | $1M | $5M | $48.7K | |
| Accounts Payable | $536.8K | $587.5K | $707.2K | $404.2K | |
| Current Liabilities | $1M | $681.0K | $1M | $986.0K | |
| Total Liabilities | $1M | $681.0K | $1M | $986.0K | |
| Paid-in Capital | $47M | $31M | $18M | $55.0K | |
| Retained Earnings | $-41M | $-31M | $-14M | $-992.3K | |
| Stockholders' Equity | $6M | $643.0K | $3M | $-937.3K | |
| Liabilities + Equity | $7M | $1M | $5M | $48.7K | |
| Shares Outstanding | 34,380,971 | 29,762,671 | 28,609,814 | 26,829,269 |
Nakit Akışı 6
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $5M | $7M | · | · | |
| Operating Cash Flow | $-4M | $-5M | $-4M | $-468.7K | |
| Stock Issued | · | $7M | $1M | · | |
| Net Stock Activity | · | $7M | $1M | · | |
| Financing Cash Flow | $10M | $6M | $4M | $470.1K | |
| Net Change in Cash | $6M | $1M | $-188 | $1.4K |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -240.3% | -542.2% | -542.1% | · | |
| ROE | -325.7% | -3047.2% | -465.5% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 5.1 | 1.9 | 0.3 | · | |
| Quick Ratio | 5.1 | 1.9 | 0.0 | · |
Değerleme (TTM) 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-10M | $-17M | $-13M | · | |
| Market Cap | $46M | $123M | · | · | |
| P/E | -4.0 | -7.4 | · | · | |
| P/B | 7.7 | 190.7 | · | · | |
| P / Tangible Book | 7.7 | 190.7 | · | · | |
| P / Cash Flow | -12.4 | -24.2 | · | · | |
| Earnings Yield | -24.8% | -13.6% | · | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $467.8K | $1M | $759.5K | $42.8K | $337.0K | $209.1K | $627.4K | $594.8K | $804.0K | $203.8K | |
| SG&A Expense | $573.5K | $838.5K | $387.0K | $5M | $2M | $3M | $5M | $879.7K | $741.5K | $395.3K | |
| Operating Expenses | $1M | $2M | $1M | $5M | $2M | $3M | $6M | $1M | $2M | $1M | |
| Operating Income | · | · | · | · | $2M | · | · | · | $2M | · | |
| Interest Expense | · | · | · | · | · | · | · | · | $4M | · | |
| Interest Income | $51.6K | $72.1K | $44.2K | $1.4K | $8.0K | $7.1K | $15.4K | $25.5K | · | · | |
| Other Non-op | $50.4K | · | · | · | $8.0K | · | $15.4K | · | · | · | |
| Net Income | $-990.9K | $-2M | $-1M | $-5M | $-2M | $-3M | $-6M | $-1M | $-6M | $-9M | |
| EPS (Basic) | $-0.03 | $-0.40 | $-0.03 | $0.17 | $-0.07 | $-0.18 | $-0.20 | $0.05 | $-0.23 | $0.62 | |
| EPS (Diluted) | $-0.03 | $-0.40 | $-0.03 | $0.17 | $-0.07 | $-0.18 | $-0.20 | $0.05 | $-0.23 | $0.62 | |
| Shares (Basic) | 34,380,971 | -60,518,648 | 32,398,906 | 30,010,165 | 29,762,671 | -58,956,890 | 29,609,814 | 29,609,814 | 29,276,481 | -53,782,878 | |
| Shares (Diluted) | 34,380,971 | -60,518,648 | 32,398,906 | 30,010,165 | 29,762,671 | -58,956,890 | 29,609,814 | 29,609,814 | 29,276,481 | -53,782,878 | |
| EBITDA | · | · | · | · | $2M | · | · | · | · | · |
Bilanço 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $7M | $7M | $754.3K | $403.0K | $1M | $834.6K | $2M | $3M | $1.2K | |
| Prepaid Expense | $229.0K | $54.7K | $72.8K | $75.3K | $88.2K | $57.9K | $77.3K | $87.8K | $98.8K | $713 | |
| Current Assets | $6M | $7M | $7M | $829.6K | $491.2K | $1M | $1M | $2M | $4M | $435.2K | |
| Total Assets | $6M | $7M | $7M | $829.6K | $491.2K | $1M | $1M | $2M | $4M | $5M | |
| Accounts Payable | $279.6K | $536.8K | $329.4K | $255.0K | $558.9K | $587.5K | $506.5K | $393.8K | $478.6K | $707.2K | |
| Current Liabilities | $827.3K | $1M | $422.8K | $348.4K | $652.3K | $681.0K | $599.9K | $534.2K | $486.6K | $1M | |
| Total Liabilities | $827.3K | $1M | $422.8K | $348.4K | $652.3K | $681.0K | $599.9K | $534.2K | $486.6K | $1M | |
| Paid-in Capital | $47M | $47M | $46M | $38M | $33M | $31M | $28M | $23M | $23M | $18M | |
| Retained Earnings | $-42M | $-41M | $-39M | $-38M | $-33M | $-31M | $-28M | $-22M | $-20M | $-14M | |
| Stockholders' Equity | $5M | $6M | $7M | $481.2K | $-161.1K | $643.0K | $442.1K | $2M | $3M | $3M | |
| Liabilities + Equity | $6M | $7M | $7M | $829.6K | $491.2K | $1M | $1M | $2M | $4M | $5M | |
| Shares Outstanding | 34,380,971 | 34,380,971 | 33,830,971 | 30,514,304 | 29,762,671 | 29,762,671 | 29,609,814 | 29,609,814 | 29,609,814 | 28,609,814 |
Nakit Akışı 6
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $39.8K | $-7.9K | $-741.9K | $5M | $1M | $2M | · | · | · | · | |
| Operating Cash Flow | $-2M | $-1M | $-927.3K | $-696.4K | $-863.1K | $-605.8K | $-1M | $-2M | $-2M | $-1M | |
| Stock Issued | · | · | $5M | · | · | · | $0 | $0 | $6M | $90.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $6M | · | |
| Financing Cash Flow | $47.4K | $1M | $8M | · | · | $1M | $-46.9K | $132.4K | $5M | $1M | |
| Net Change in Cash | $-2M | $-42.6K | $7M | $351.3K | $-863.1K | $431.5K | $-1M | $-1M | $3M | $-1.2K |
Kârlılık 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -31.6% | · | -26.1% | -345.9% | -109.1% | · | -1149.9% | -137.9% | -357.1% | · | |
| ROE | -41.3% | · | -29.7% | -494.9% | -152.7% | · | -2710.3% | -184.9% | -414.7% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 17.5 | 2.4 | 0.8 | · | 1.7 | 3.9 | 7.2 | · | |
| Quick Ratio | 6.7 | · | 17.3 | 2.2 | 0.6 | · | 1.4 | 3.5 | 6.7 | · |
Değerleme (TTM) 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-9M | · | $-14M | $-15M | $-16M | · | $-23M | $-19M | $-19M | · | |
| Market Cap | $45M | · | $47M | $38M | $96M | · | $190M | $142M | $152M | · | |
| P/E | 32.5 | · | -10.7 | -25.0 | -7.2 | · | -14.6 | -16.0 | -13.9 | · | |
| P/B | 9.0 | · | 6.7 | 79.3 | -596.7 | · | 430.0 | 90.9 | 50.6 | · | |
| P / Tangible Book | 9.0 | · | 6.7 | 79.3 | · | · | 430.0 | 90.9 | 50.6 | · | |
| P / Cash Flow | -25.2 | · | · | · | -111.4 | · | · | · | -78.6 | · | |
| Earnings Yield | 3.1% | · | -9.3% | -4.0% | -13.9% | · | -6.9% | -6.2% | -7.2% | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Net Gelir | $-10M | $-17M | $-13M | $-854.1K |
| Seyreltilmiş Hisse Başı Kâr | $-0.33 | $-0.56 | $0.48 | $-0.03 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Cari Oran | 5.1 | 1.9 | 0.3 | — |
| Cari Oran | 5.1 | 1.9 | 0.0 | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.